1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,124 | 0,286 | 16:06 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | NEEM S HILL AB: Neem's Hill AB (publ) publishes Interim report Q3 2026 | 1 | Cision News | ||
| Di | Neem's Hill AB: Neem's Hill AB (publ) publishes Interim report Q3 2026 | 96 | GlobeNewswire (Europe) | The report is attached to this press release and can also be downloaded from the company's website
January - September 2026
Net sales amounted to 9,466 kSEK (9,637)
Profit/loss after... ► Artikel lesen | |
| 22.09. | NEEM S HILL AB: Neem's Hill - Building the Next Chapter | 1 | Cision News | ||
| NEEMS HILL Aktie jetzt für 0€ handeln | |||||
| 22.09. | Neem's Hill AB: Neem's Hill - Building the Next Chapter | 189 | GlobeNewswire (Europe) | Neem's Hill AB (publ) provides a shareholder update on the Group's development, highlighting an installed base now exceeding 60 vetIQure systems and more than 4,500 Animal Care treatments sold.FROM... ► Artikel lesen | |
| 11.08. | NEEM S HILL AB: Neem's Hill AB (publ) publishes Interim report Q2 2026 | 1 | Cision News | ||
| 11.08. | Neem's Hill AB: Neem's Hill AB (publ) publishes Interim report Q2 2026 | 632 | GlobeNewswire (Europe) | The report is attached to this press release and can also be downloaded from the company's website
January - June 2026
Net sales amounted to 6,090 KSEK (6,313)
Profit/loss after financial... ► Artikel lesen | |
| 13.07. | Neem's Hill AB: Scandinavian ChemoTech AB changes name to Neem's Hill AB | 349 | GlobeNewswire (Europe) | Former Scandinavian ChemoTech AB, has completed the name change to Neem's Hill AB ("Neem's Hill" or "the Company"), which was resolved at the Annual General Meeting held on 5 May 2026. The name change... ► Artikel lesen | |
| 10.07. | Change of issuer name for Scandinavian ChemoTech AB | 482 | GlobeNewswire | As from July 13, 2026, Scandinavian ChemoTech AB will change issuer name
Company name is Neem's Hill AB.
Old issuer name: Scandinavian ChemoTech AB
New issuer name: Neem's Hill AB
New... ► Artikel lesen | |
| 02.06. | Scandinavian ChemoTech AB: Scandinavian ChemoTech secures SEK 6 million Growth Loan from a larger Swedish Financial Institution | 254 | GlobeNewswire (Europe) | Scandinavian ChemoTech has secured a SEK 6 million growth loan from a larger financial institution in Sweden.
The financing forms part of ChemoTech's long-term financial strategy and will support the... ► Artikel lesen | |
| 28.04. | Scandinavian ChemoTech AB: Scandinavian ChemoTech AB (publ) publishes Interim report Q1 2026 | 371 | GlobeNewswire (Europe) | The report is attached to this press release and can also be downloaded from the company's website January - March 2026
Net sales amounted to 2,798 KSEK (2,472)
Profit/loss after... ► Artikel lesen | |
| 07.04. | Scandinavian ChemoTech AB: ChemoTech's Proposed Strategic Changes Accepted by Nasdaq First North | 273 | GlobeNewswire (Europe) | Scandinavian ChemoTech AB (publ) (the "Company") today announces that, based on information disclosed in the Company's press releases published on Tuesday, March 31, ahead of the notice of the Annual... ► Artikel lesen | |
| 01.04. | Scandinavian ChemoTech AB: Scandinavian ChemoTech Starts 2026 Strong with Best First Quarter in Company History | 276 | GlobeNewswire (Europe) | Scandinavian ChemoTech's Animal Care continues its strong commercial momentum, delivering its best first quarter in the company's history in Q1 2026, with sales amounting to approx. 299,000 USD compared... ► Artikel lesen | |
| 31.03. | Scandinavian ChemoTech AB: Scandinavian ChemoTech proposes expanded business activities, name change & received proposal on directed issue | 387 | GlobeNewswire (Europe) | NOT FOR DISCLOSURE, DISTRIBUTION OR PUBLICATION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR TO THE UNITED STATES, AUSTRALIA, BELARUS, HONG KONG, JAPAN, CANADA, NEW ZEALAND, RUSSIA, SWITZERLAND... ► Artikel lesen | |
| 17.02. | Scandinavian ChemoTech AB: Scandinavian ChemoTech AB (publ) publishes Year-end report 2025 | 363 | GlobeNewswire (Europe) | The report is attached to this press release and can also be downloaded from the company's website.
October - December 2025
Net sales amounted to 2,648 KSEK (2,041)
Profit/loss after... ► Artikel lesen | |
| 05.01. | Scandinavian ChemoTech AB: New Year's Letter to Shareholders in Scandinavian ChemoTech - Reflecting on 2025 | 508 | GlobeNewswire (Europe) | Dear Shareholders,
As we enter 2026, I would like to thank you for your continued trust and support of Scandinavian ChemoTech. The past year, 2025, has been an important one for the Company, a year... ► Artikel lesen | |
| 04.11.25 | Scandinavian ChemoTech AB: Scandinavian ChemoTech AB (publ) publishes Interim Report Q3 2025 | 314 | GlobeNewswire (Europe) | The report is attached to this press release and can also be downloaded from the company's website.
July - September 2025 ... ► Artikel lesen |
16 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS MEDICAL CARE | 40,460 | -2,44 % | JPMORGAN stuft FMC FRESENIUS MEDICAL CARE AG auf 'Underweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat FMC auf "Underweight" mit einem Kursziel von 32,30 Euro belassen. Entgegen seinen Erwartungen seien die Konsensschätzungen an die Quartalszahlen... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 67,18 | +11,56 % | BrightSpring Health Q3 2026 Earnings Call Transcript | ||
| SIEMENS HEALTHINEERS | 43,040 | +0,35 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
| FRESENIUS | 47,680 | +1,45 % | BERENBERG stuft Fresenius SE auf 'Buy' | HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat das Kursziel für Fresenius von 50 auf 54 Euro angehoben und die Einstufung auf "Buy" belassen. Der Markt bewerte den Medizinkonzern als vom... ► Artikel lesen | |
| GERRESHEIMER | 32,960 | +3,32 % | Kurssprünge und neue Aufträge: Wie belastbar ist die Wende? dynaCERT, Gerresheimer, Steyr Motors | Ein Übernahmeangebot, internationale Vertriebsfortschritte und ein Konzernumbau bringen Bewegung in die folgenden drei Börsenwerte. Während Anleger auf neue Wachstumsimpulse und finanzielle Entlastung... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 7,270 | -9,80 % | Piper Sandler cuts Alignment Healthcare stock price target on weak guidance | ||
| HEARTFLOW | 57,79 | -4,53 % | Biotech Stocks At 52-Week Highs - Vaxcyte +31% On Phase 3 Results, InfuSystem, Illumina +7%, Charles River Laboratories +7%, HeartFlow +5% | SAN DIEGO (dpa-AFX) - The following biotech stocks reached a 52-week high on October 5, 2026, driven by key catalysts such as encouraging clinical research data.Vaxcyte Inc. (PCVX)Vaxcyte is... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 35,620 | +2,47 % | JPMORGAN stuft CARL ZEISS MEDITEC AG auf 'Underweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat Carl Zeiss Meditec auf "Underweight" mit einem Kursziel von 18,10 Euro belassen. Für die Quartalszahlen am 10. Dezember liege er beim Umsatz auf... ► Artikel lesen | |
| GENEDX | 69,69 | -1,88 % | GeneDx plans to add long-read genome sequencing to portfolio | ||
| ECKERT & ZIEGLER | 13,435 | +1,63 % | EQS-News: Eckert & Ziegler SE: Eckert & Ziegler Erhält GMP-Zertifizierung für Actinium-225 | EQS-News: Eckert & Ziegler SE
/ Schlagwort(e): Zulassungsgenehmigung
Eckert & Ziegler Erhält GMP-Zertifizierung für Actinium-225
28.10.2026 / 14:00 CET/CEST
Für den... ► Artikel lesen | |
| UNITEDHEALTH | 365,40 | -0,92 % | UnitedHealth Group To Rally Over 29%? Here Are 10 Top Analyst Forecasts For Tuesday | ||
| ESSILORLUXOTTICA | 184,75 | +3,44 % | 263 Prozent mehr KI-Brillen: Wie Meta und EssilorLuxottica den Optikmarkt verändern | ||
| BILLIONTOONE | 112,19 | -2,31 % | BillionToOne, Inc.: BillionToOne's Tissue-Free Northstar Response Demonstrates On-Par to Superior Cancer Treatment Monitoring vs. Tumor-Informed Assay, New Peer-Reviewed Study Finds | MENLO PARK, Calif., Oct. 07, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (Nasdaq: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 13,470 | 0,00 % | LifeStance Health Group, Inc.: LifeStance Reports Strong Second Quarter 2026 Financial Results and Raises Full Year Outlook | SCOTTSDALE, Ariz., Aug. 06, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen | |
| MEDTRONIC | 86,94 | +0,02 % | Medtronic Spark Scholarship Applications Now Open for Students Pursuing Careers in Healthcare Technology | Up to 100 scholarships will be awarded globally to students pursuing degrees or credentials in health tech fields. NORTHAMPTON, MA / ACCESS Newswire / October 28, 2026 / Medtronic, a global leader in... ► Artikel lesen |
NEEMS HILL AB gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von 0,000 (0,00 %) liegt der Kurs bei 0,148 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu NEEMS HILL AB finden Sie auf Wallstreet Online.